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ABSTRACT
Objectives: Downbeat nystagmus (DBN) is the most
common form of acquired involuntary ocular oscillation
overriding fixation. According to previous studies, the
cause of DBN is unsolved in up to 44% of cases. We
reviewed 117 patients to establish whether analysis of a
large collective and improved diagnostic means would
reduce the number of cases with ‘‘idiopathic DBN’’ and
thus change the aetiological spectrum.
Methods: The medical records of all patients diagnosed
with DBN in our Neurological Dizziness Unit between
1992 and 2006 were reviewed. In the final analysis, only
those with documented cranial MRI were included. Their
workup comprised a detailed history, standardised
neurological, neuro-otological and neuro-ophthalmological
examination, and further laboratory tests.
Results: In 62% (n = 72) of patients the aetiology was
identified (‘‘secondary DBN’’), the most frequent causes
being cerebellar degeneration (n = 23) and cerebellar
ischaemia (n = 10). In 38% (n = 45), no cause was found
(‘‘idiopathic DBN’’). A major finding was the high
comorbidity of both idiopathic and secondary DBN with
bilateral vestibulopathy (36%) and the association with
polyneuropathy and cerebellar ataxia even without
cerebellar pathology on MRI.
Conclusions: Idiopathic DBN remains common despite
improved diagnostic techniques. Our findings allow the
classification of ‘‘idiopathic DBN’’ into three subgroups:
‘‘pure’’ DBN (n = 17); ‘‘cerebellar’’ DBN (ie, DBN plus
further cerebellar signs in the absence of cerebellar
pathology on MRI; n = 6); and a ‘‘syndromatic’’ form of
DBN associated with at least two of the following:
bilateral vestibulopathy, cerebellar signs and peripheral
neuropathy (n = 16). The latter may be caused by
multisystem neurodegeneration.
Downbeat nystagmus (DBN) is the most common
form of acquired involuntary ocular oscillations
overriding fixation. It is characterised by slow
upward drifts and fast downward phases. Slow
phase velocity increases on lateral and downward
gaze and convergence, although there may be
atypical presentations with enhancement of DBN
on upward gaze or suppression on convergence.1
The most common presenting symptoms are
unsteadiness of gait and to-and-fro vertigo. On
further inquiry, patients frequently report blurred
vision or oscillopsia that increases on lateral gaze.
DBN is often associated with other oculomotor
disorders, predominantly smooth pursuit deficits
and impairment of the optokinetic reflex and
visual fixation suppression of the vestibulo-ocular
reflex (VOR).
DBN may be caused by lesions of the vestibul-
ocerebellum and, rarely, bilateral paramedian
brainstem pathology.2 In a large proportion of
patients, however, no anatomical lesion can be
identified (so-called idiopathic DBN).3 The patho-
physiology underlying DBN is still controversial.
An inherent asymmetry of peripheral vestibular
input has been proposed as well as central
imbalance in the vertical vestibulo-ocular sys-
tem.4–6 Others suggest an imbalance of the smooth
pursuit system or a mismatch of the coordinate
systems of the saccadic burst generator and the
neural eye-velocity-to-position integrator.7–9
The aetiology of DBN is diverse. Craniocervical
malformations, cerebellar degeneration, vascular
pathology, inflammatory disease and intoxication
with lithium or antiepileptic drugs have, among
others, been implicated.3 5 10–12 In one of the first
descriptions of this condition, DBN due to
cerebellar ectopia (Arnold–Chiari-malformation
(ACM)) was reported.13 In the first survey on
DBN, craniocervical malformations were diagnosed
in eight of 27 patients and thus topped the list of
underlying aetiologies.14 In one of the most
comprehensive surveys of this condition to date,
these disorders remained one of the most frequent
single identified causes of DBN (ACM in 17 of 62
patients).3 In this study, no cause for DBN could be
determined in 27 of 62 patients. These retro-
spective studies, however, were performed before
the general availability of MRI. Thus lacunar
infarctions, demyelinating plaques and other subtle
lesions of the posterior fossa may not have been
detected. In a small study of 24 patients with DBN
examined by MRI, ACM and cerebellar degenera-
tion remained the commonest causes of DBN.15
To determine if this aetiological spectrum still
holds true in an analysis of a large collective with
thorough imaging or whether the predominance of
craniocervical malformations can be overturned
and the number of cryptogenic DBN reduced by
improved diagnostic means, we retrospectively
analysed the findings in 117 patients who had all
undergone cranial MR imaging and standardised
neurological, neuro-ophthalmological and neuro-
otological examinations.
PATIENTS AND METHODS
To retrospectively determine the frequency of
DBN among congenital and acquired ocular oscilla-
tions that override fixation, the files of 4854
consecutive patients from our dizziness unit were
analysed.
The medical records of 136 patients diagnosed as
having DBN in the Neurological Dizziness Unit of
the University of Munich over a 14 year period
between 1992 and 2006 were reviewed. A detailed
standardised history was taken for all patients. The
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following parameters, all of them relevant to inclusion /
exclusion of differential diagnoses of vertigo and dizziness,
were assessed.
1. Vertigo/dizziness/unsteadiness of gait: onset, duration,
time course, frequency, associated visual and ocular motor
symptoms (including oscillopsia, double vision, blurred
vision or loss of sight), associated otological symptoms
(including tinnitus, hearing loss, fullness of the ear),
associated cerebellar symptoms (ataxia, dysarthria) and
other concurrent symptoms, such as headache, phonopho-
bia, photophobia, nausea and vomiting
2. Past medical history, with particular reference to migraine,
polyneuropathy (PNP), exposure to toxins, ethanol,
lithium, amiodarone or antiepileptic medication, cardiovas-
cular risk factors (eg, arterial hypertension, diabetes
mellitus) and systematic inquiry of other neurological,
ophthalmological, ENT and medical diseases
3. Family history
Patients underwent a full and standardised neurological,
neuro-otological and neuro-ophthalmological examination with
special emphasis on spontaneous nystagmus with Frenzel’s
goggles in the primary position, lateral and vertical gaze
direction, gaze evoked nystagmus, smooth pursuit, saccades,
optokinetic nystagmus, visual fixation suppression of the VOR,
rebound nystagmus, head shaking nystagmus, head thrust test,
eye position in roll with a scanning laser ophthalmoscope and
determination of the subjective visual vertical.
Electronystagmography
Electronystagmography with bithermal caloric testing (30uC
and 44uC) was performed in 71 patients. The mean peak slow
phase velocity (SPV) was determined with Igor Pro Wave Metric
(V.3.13) software. Vestibulopathy was defined as nystagmus
with an SPV ,5u/s per irrigation.
Other laboratory tests
Specific laboratory tests included cranial MRI (n = 117),
auditory evoked potentials and/or an audiogram (n = 27),
vitamin B12 (n = 50), folate (n = 48), vitamin E (n = 24),
glutamic acid decarboxylase antibodies (n = 8), magnesium
(n = 20) and CSF chemistry (n = 62).
PNP was diagnosed in those patients with electromyographic
signs of axonal and/or demyelinating PNP and in those with a
significantly reduced sense of vibration (4/8 or less in the tuning
fork test).
Statistics
Data were collected and evaluated by means of Excel (Microsoft
Corp.) spreadsheet software. Comparison between categorical
values was performed using a x2 test. Metric values were
compared by a Mann–Whitney U test. Significance was defined
as an alpha level of 0.05.
RESULTS
Of a total of 5904 patients in our department between 1992 and
2006, 136 had been diagnosed as having DBN. DBN was found
to be the most common form of involuntary fixation
nystagmus of central origin (table 1). Only those patients
who had cranial MRI (n = 117) were included in the final
analysis. They were evaluated for aetiology, epidemiology,
presentation and associated findings.
Aetiology
In 62% (72 of 117) of patients with DBN, a possible (n = 46) or
definite (n = 26) causative factor was identified. The most
frequent single identifiable cause of DBN in our patients was
cerebellar degenerative disease (20%, n = 23). This group
included multisystem atrophy (according to the diagnostic
criteria of the International Consensus Conference), spinocere-
bellar ataxia (ataxia with suspected autosomal dominant
inheritance) and sporadic adult onset ataxia (progressive ataxia
without established symptomatic cause).16 17 In one patient, the
diagnosis (spinocerebellar ataxia 6) was confirmed by genetic
testing.
Degenerative cerebellar disease as a cause for DBN was
followed in frequency by posterior fossa vascular lesions (9%,
n = 10), and craniocervical malformations with cerebellar
ectopia (7%, n = 8) (fig 1; for a list of individual entities
included in the diagnostic groups listed above see tables 2 and
3).
In 38% (n = 45) of all patients with DBN, no causative factor
was identified. In these cases DBN was therefore considered
idiopathic. As ‘‘idiopathic DBN’’ might represent a distinct
nosological entity of unknown aetiology, it will henceforth be
considered separately, especially in terms of its association with
other neurological symptoms.
Age and gender
Median age of all DBN patients was 62 years (range 10–92). In
those with idiopathic DBN, median age was 67 years with a
peak between the seventh and eighth decade (range 24–92).
Patients with secondary DBN had a mean age of 59 years, with
the peak onset in the seventh decade (range 10–82 years) (fig 2).
Thus patients with idiopathic DBN were older than those with
secondary DBN (p,0.001). Whereas the male-to-female ratio
was roughly equal in idiopathic DBN, there was a slight female
preponderance in secondary DBN (total male to female: 55% vs
45%; idiopathic: 51% vs. 49%; secondary: 41% vs 59%).
Characteristic features of DBN
A typical feature of DBN is enhancement of the SPV on lateral
gaze. Some patients, however, lack enhancement or even
exhibit a reduction in SPV. In our series, SPV increased on
lateral gaze in 77% (n = 90) of patients and there was no SPV
enhancement in 18% (n = 21) of patients (n = 41 vs n = 4 in
idiopathic DBN and n = 49 vs n = 17 in secondary DBN). In six
patients, modulation of DBN on lateral gaze had been
insufficiently documented. Idiopathic DBN was more often
Table 1 Frequency of congenital and/or acquired ocular oscillations in
a total of 4854 consecutive patients seen between 1995 and 2006 in our
neurological dizziness unit
Type of nystagmus/ocular oscillation n
Downbeat nystagmus 101
Upbeat nystagmus 54
Central positional nystagmus 26
Pendular nystagmus 15
Congenital nystagmus 12
Torsional nystagmus 12
See-saw nystagmus 8
Ocular flutter 8
Square wave jerks 7
Opsoclonus 1
Periodic alternating nystagmus 1
Downbeat nystagmus was the most frequent fixation nystagmus.
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associated with enhancement of the nystagmus on lateral gaze
than secondary DBN (p,0.05).
In 64% (n = 29) of patients with idiopathic and 82% (n = 59)
of those with secondary DBN, SPV increased on downward and
decreased on upward gaze. In 6% (n = 3) of patients with
idiopathic and none of those with secondary DBN, SPV
increased on upward gaze. Convergence enhanced SPV in 64%
(n = 29) of patients with idiopathic and 61% (n = 44) of
patients with secondary DBN. Dependency of SPV on vertical
gaze position and convergence was not statistically different
between idiopathic and secondary DBN.
In nine patients (six with idiopathic, three with secondary
DBN), dependency of the SPV on head position was tested. In
seven (four idiopathic DBN, three secondary DBN) patients,
SPV decreased when the patient was supine and increased when
he was prone. In one patient with idiopathic DBN, SPV
increased in both the supine and prone positions while in
another it decreased in both positions.
Presenting symptoms and clinical signs
The most common presenting symptom was unsteadiness of
gait or to-and-fro vertigo (idiopathic 89%; secondary 81%).
Most patients with idiopathic or secondary DBN reported
permanent rather than episodic symptoms (93% vs 94%).
Oscillopsia was reported by 44% with idiopathic compared
with 38% with secondary DBN.
Associated neurological findings
Peripheral vestibular deficits
A frequent finding in patients with DBN was unilateral or
bilateral vestibulopathy. Vestibulopathy was defined as a
reduced response to caloric irrigation and/or a pathological
head thrust test. Forty-five patients had undergone either
caloric irrigation or head thrust tests, 36 had undergone both
and in 36 patients (28 with secondary, eight with idiopathic
DBN) peripheral vestibular function was not tested. Of those
tested, 32% of patients with idiopathic DBN and 39% with
Figure 1 Aetiology of downbeat
nystagmus (DBN). Relative frequencies of
idiopathic and secondary DBN are shown.
Causes of secondary DBN are specified
(percentages refer to frequency relative to
all DBN cases). GAD, glutamic acid
decarboxylase.
Table 2 Details of aetiological entities underlying secondary downbeat
nystagmus
Aetiology n
Degenerative 23
Spinocerebellar ataxia 13
Sporadic adult onset ataxia 9
Multisystem atrophy (cerebellar type) 1
Posterior fossa vascular lesions 10
Craniocervical malformation 8
Arnold–Chiari malformation type I 7
Arnold–Chiari malformation type II 1
Toxic 5
Chronic ethanol abuse with cerebellar atrophy 1
Chronic ethanol abuse without cerebellar atrophy 1
Anticonvulsants (phenytoin, carbamazepine) 2
Amiodarone 1
Inflammatory/infectious 4
Pancerebellar syndrome post-tick borne encephalitis 1
Cerebellitis of unclear aetiology 1
Chronic aseptic meningitis 1
Pontine encephalitis 1
Neoplastic 4
Pontomedullary astrocytoma 1
Cerebellar meningeoma 1
Ependymoma; hydrocephalus 1
Plexus papilloma 4th ventricle 1
Episodic ataxia type 2 4
Paraneoplastic 3
Paraneoplastic (anti-yo/anti-Purkinje-Cell positive) 2
Paraneoplastic (anti-yo/anti-Purkinje-Cell negative) 1
Other 11
Table 3 Localisation of lesions in patients with downbeat nystagmus
secondary to vascular pathology
Patient
No Localisation
1 Thrombosis of the basilar artery; ischaemic infarction of the left caudate, left
paramedian mesencephalon, small ischaemic lesions in both cerebellar
hemispheres
2 Sudden onset of symptoms, diffuse microangiopathic changes
3 Venous angioma paramedially pontomesencephal; two small ischaemic
lesions in both cerebellar hemispheres
4 Infarction of the left superior cerebellar artery
5 Dissection of both vertebral arteries; infarctions of both cerebellar
hemispheres
6 Infarction of the left anterior and posterior inferior cerebellar artery with
involvement of the left tonsilla, cerebellar peduncle and the pontine
tegmentum
7 Infarction of both cerebellar hemispheres and in the area of the right posterior
cerebral artery
8 Stenosis of the left vertebral artery; defect of the left cerebellar tonsilla.
9 Pontomesencephalic arteriovenous malformation
10 Brainstem haemorrhage on the basis of a pontomesencephalic venous
malformation
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secondary DBN had bilateral vestibular deficits. Of those who
had undergone both caloric irrigation and head thrust tests
(n = 36), 19 had bilateral vestibulopathy. In nine of these, both
tests showed bilateral vestibular deficits. Eight had pathological
head thrust tests with normal caloric excitability and two
patients exhibited diminished peripheral vestibular caloric
response with bilateral (n = 1) or unilateral (n = 1) physiological
head thrust tests.
Polyneuropathy
PNP was frequently associated with DBN (16 patients with
idiopathic, 18 with secondary DBN). Patients with known
aetiologies of PNP, such as diabetes mellitus (n = 9), were
excluded from this group. The neuropathies diagnosed were
heterogeneous, including sensory, motor, demyelinating, axonal
and mixed types.
Cerebellar signs
Cerebellar signs, including limb ataxia and dysarthria, were
frequently seen in the ‘‘secondary DBN’’ group (limb ataxia in
70% and dysarthria in 46%). They were also present in patients
with idiopathic DBN (limb ataxia in 42% and dysarthria in
13%)—that is, those patients who did not have cerebellar
lesions on MRI or evidence of cerebellar disease in other
technical investigations.
Notably, there was considerable overlap between idiopathic
DBN, cerebellar signs, bilateral vestibulopathy and peripheral
neuropathy (fig 3). Thirteen patients had DBN associated with
varying combinations of two of these disorders and, in three
patients, with all three of them.
Associated neuro-ophthalmological findings
The most frequent ophthalmological findings associated with
DBN were saccadic vertical and horizontal smooth pursuit
(idiopathic DBN 97% and secondary DBN 99%), impaired
vertical optokinetic reflex (idiopathic DBN 85%, secondary DBN
87%) and impaired horizontal fixation suppression of the VOR
(idiopathic DBN 73%, secondary DBN 70%). Other pathologies
included incomplete ocular tilt with deviation of the subjec-
tive visual vertical and/or ocular torsion (idiopathic DBN
38%, secondary DBN 41%), dysmetric/slowed saccades (idio-
pathic DBN 31%, secondary DBN 59%), rebound nystagmus
(idiopathic DBN 18%, secondary DBN 29%) and head shaking
nystagmus (idiopathic DBN 11%, secondary DBN 16%).
Ancillary findings
Cranial imaging
A cranial MRI was obtained for all 117 patients. An experienced
neuroradiologist detected cerebellar atrophy in 27 patients and
other cerebellar lesions in 13 patients. Brainstem lesions were
present in 11 patients.
Serum chemistry
Vitamin B12 serum levels were determined in 50 patients. Two
had markedly diminished levels (146 pg/ml, 95 pg/ml). B12 was
only slightly reduced in two others (211 pg/ml, 239 pg/ml;
normal range 250–900). Vitamin E levels were determined in 24
patients; all were within the normal range or elevated.
Furthermore, magnesium levels were determined in 20 patients,
all of which were normal.
Glutamic acid decarboxylase antibody levels were determined
in eight patients. Markedly raised serum levels were detected in
a 56-year-old male with a history of chronic lymphocytic
leukaemia (80.2 U/ml; normal range ,0.9).
Spinal fluid
A spinal tap was performed in 62 patients. Six patients had a
raised cell count (range 8–229 cells), nine patients raised CSF
protein (range 50–150 mg/dl) and six patients had CSF specific
oligoclonal bands. The diagnoses in patients with pathological
CSF included cerebellitis, pontine encephalitis and paraneoplas-
tic disease.
Drugs
Amiodarone toxicity was the cause of DBN in one patient,
whose nystagmus disappeared after discontinuation of the drug.
In two of nine patients on anticonvulsive medication at the
time of diagnosis, drug toxicity was deemed responsible for the
DBN: a 73-year-old female with blood phenytoin levels of
Figure 2 Age distribution of patients with downbeat nystagmus (DBN),
presented separately for idiopathic and secondary DBN.
Figure 3 Overlap of idiopathic downbeat nystagmus with peripheral
neuropathy, cerebellar signs and bilateral vestibulopathy. Absolute
numbers are given.
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30.3 mg/ml and a 58-year-old female on carbamazepine and
vigabatrin.
DISCUSSION
This retrospective study has shown that despite improved
diagnostic means, especially the use of high resolution MRI, the
percentage of patients in whom no aetiology of DBN could be
determined, so-called ‘‘idiopathic DBN’’, remains high (38%).
This parallels values obtained in earlier studies performed before
the general availability of MRI and/or with smaller samples
(idiopathic DBN in 25–44% of patients).3 14 15 While our study
has reaffirmed the preponderance of cerebellar degeneration,
posterior fossa vascular lesions and cerebellar ectopia among the
causes of secondary DBN, it has also found new aspects
connected with the comorbidity, classification and possible
pathomechanisms of DBN.
Association of DBN with bilateral vestibulopathy, cerebellar
ataxia and polyneuropathy
A major finding of this study was the association of idiopathic
as well as secondary DBN with bilateral vestibulopathy (BVP),
as demonstrated by head thrust tests or caloric irrigation. The
prevalence of DBN and BVP is not known. In our neurological
ocular motor and dizziness unit, BVP accounts for 4% and DBN
for 2.3% of the diagnoses. The common comorbidity of BVP and
DBN (32% in idiopathic and 39% in secondary DBN) suggests a
common pathomechanism. This is supported by a recent study
on 255 patients with BVP, 17 (7%) of whom also had DBN.18
Apart from BVP, cerebellar ataxia and dysarthria were
identified as frequent concurrent symptoms. The association
of DBN with cerebellar symptoms is not surprising as DBN is
caused by a cerebellar, namely Purkinje cell, dysfunction. Forty-
two per cent of patients who fulfilled the criteria of so-called
idiopathic DBN had cerebellar symptoms, although usually
subtle ones. In this group of patients, MRI detected no
cerebellar atrophy or other cerebellar lesions. At this point,
however, we cannot exclude the fact that at least a subgroup of
these patients presented at an early stage of a cerebellar
degenerative disease before overt cerebellar atrophy. Therefore,
follow-up-studies are required.
The third clinical entity frequently coexistent with DBN was
PNP (36% in idiopathic and 25% in secondary DBN). These
numbers may be biased by the advanced age of our sample. In a
community based survey, PNP had a prevalence of 19% in a
population between the ages of 65 and 74 years who had no
disease known to cause PNP.19
Among the group fulfilling the current criteria for idiopathic
DBN, a subgroup of 16 patients (36%) were identified in whom
DBN was associated with two or all of the following disorders:
cerebellar signs, BVP and/or PNP. In a recent study on four
patients with cerebellar ataxia and bilateral vestibulopathy,
three patients also had sensory neuropathy and one patient
DBN.20 In these patients, however, MRI revealed cerebellar
atrophy. Thus to the best of our knowledge this is the first
sample of patients with the specific association of DBN, BVP,
PNP and cerebellar signs without imageable cerebellar atrophy.
Pathomechanisms of DBN
DBN has long been associated with cerebellar lesions, particu-
larly with those of the floccular and parafloccular lobes.8 21–23
Several models of the pathomechanism of DBN have been
suggested, among them an imbalance in the smooth pursuit
system, or a central or peripheral vestibular imbalance.4–7 24
Recent therapeutic advances with 4-aminopyridine, a potassium
channel blocker, support this hypothesis. This agent may
enhance the inhibitory output of floccular Purkinje cells on
vestibular nuclei and thus alleviate DBN.25
On the basis of our findings that DBN frequently coexists
with BVP, we suggest a potential pathophysiology of idiopathic
DBN. In our collective, DBN was predominantly associated
with high frequency vestibular deficits. This is particularly
interesting in the light of recent findings on murine CACNA1A
mutants, in which calcium currents through P/Q channels are
reduced.26 27 These channels are particularly numerous in
cerebellar Purkinje cells. The mutants ‘‘tottering’’ and ‘‘rocker’’
exhibit an upward elevation of average vertical eye position, a
finding possibly analogous to DBN in humans. In these
mutants, VOR gain is reduced only at high stimulus frequen-
cies. This parallel supports the view that a channelopathy
might be the underlying cause in some cases of idiopathic
DBN, a hypothesis that is further backed by the finding that
4-aminopyridine not only decreases DBN SPV but also improves
horizontal and vertical VOR gain.28
Another interesting feature of the murine mutants described
by Stahl and colleagues26 27 is that they exhibit no or little
vertical eye displacement at birth. With advancing age,
however, the ocular upward elevation increases. DBN, and
particularly idiopathic DBN, in humans is a disorder of the
elderly (fig 2). Therefore, we suggest that a genetic polymorph-
ism of the CACNA1A gene predisposes to development of DBN,
which becomes manifest if additional degenerative changes
develop with ageing. Further genetic and molecular studies need
to be performed to prove these hypotheses.
Clinical resume
Neurologists should be familiar with DBN as it is the most
common form of involuntary central fixation nystagmus. They
should always look for DBN in a patient complaining of gait
unsteadiness as this is the most common presentation.
Particular attention should be paid to associated BVP, cerebellar
symptoms and PNP. On the basis of our results, we suggest a
subgrouping of ‘‘idiopathic DBN’’: (1) patients with ‘‘pure’’
DBN who have no other signs or symptoms except for the
oculomotor disorders commonly associated with floccular
disorders (ie, impaired smooth pursuit, optokinetic reflex and
fixation suppression of the VOR); (2) a ‘‘cerebellar’’ form (ie,
DBN associated with cerebellar ataxia or dysarthria but without
cerebellar atrophy on routine MRI). This form may be a distinct
nosological entity or the early manifestation of another
cerebellar degenerative disease. Follow-up studies will be needed
to clarify this issue; and (3) a ‘‘syndromatic’’ form (ie, DBN
associated with at least two of the following: BVP, cerebellar
signs and/or PNP). The association of these disorders suggest
that this syndrome may reflect a multisystem neurodegenera-
tion or channelopathy.
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